Reuters: Health
GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.
GSK to produce 1 bln doses of coronavirus vaccine booster in 2021
GSK to produce 1 bln doses of coronavirus vaccine booster in 2021
Reuters: Health
GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.
Reuters: Health
GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment